At Boston Medical Center (BMC), the care of patients with breast cancer is a collaborative, multidisciplinary process. BMC’s Breast Health Program incorporates a coordinated multispecialty approach to care, bringing together the expertise of diverse specialists to manage care from the first consultation through treatment and follow-up visits.
"I hope you guys never get sick, but if you do Dr. Ko is the best there is she will never stop working to give you the best care there is. She is wonderful and she has a great team everyone is so caring and wonderful I love them."
To schedule an appointment or refer a patient, call us at 617.638.2778. All new patients are given expedited appointments in the Belkin Breast Health Center, where they are seen by either a medical or surgical breast specialist.
To learn more about BMC’s Breast Health Program and the Belkin Breast Health Center, proud recipient of grants from Susan G. Komen for the Cure and the Avon Breast Cancer Foundation, please visit the Belkin Breast Health Center website.
What Is Breast Cancer?
Excluding skin cancer, breast cancer is the most common type of cancer among women in the U.S. (American Cancer Society 2015b).
The normal breast is composed of 15 to 20 sections called lobes. Each lobe is made up of smaller sections called lobules. Lobules contain small groups of glands that produce breast milk. Thin tubes, called ducts, carry the milk from the lobules to the nipple. The breast also contains blood vessels and lymph vessels. Lymph vessels are similar to blood vessels, but instead of circulating blood throughout the body, they circulate a clear fluid called lymph. The lobes, lobules, ducts, blood vessels, and lymph vessels are surrounded by fatty and connective tissue called stroma.
Cancer cells in the breast form a malignant (cancerous) tumor that appears as a lump. However, not all breast lumps are cancerous. In fact, most breast lumps are benign (noncancerous). Benign breast lumps are abnormal growths that do not spread outside the breast and are generally not life threatening. They can be caused by fibrocystic changes, a combination of cysts (fluid-filled sacs) and fibrosis (the formation of scar-like tissue) in the breast. Benign lumps can be painful and may cause swelling, particularly when a woman is just about to start her menstrual cycle. These changes can also make the breast feel lumpy and cause a clear or slightly cloudy discharge from the nipple.
Most breast cancers are carcinomas, or cancers that begin in the lining of organs. There are several types of breast cancer. "In situ" means the cancer is confined to the tissue where it began. "Invasive" refers to cancer that has spread from the layer of tissue where it began into surrounding healthy tissue.
Ductal Carcinoma in Situ (DCIS)
Cancer that starts in the lining of the duct but does not grow through the walls of the duct into the surrounding breast tissue and beyond is called ductal carcinoma in situ (DCIS). The cancer cells cannot spread to the lymph nodes (small, oval-shaped tissues containing certain infection-fighting immune system cells) or other organs. Ductal carcinoma in situ can go on to become invasive cancer. It is sometimes called a precancer. Almost all women diagnosed with ductal carcinoma in situ can be cured. Many cases are caught by mammograms.
Invasive Ductal Carcinoma (IDC)
Invasive ductal carcinoma (IDC) starts in the lining of the duct but breaks through the wall of the duct into the surrounding breast tissue. From there it can spread to the lymph nodes and other organs. Invasive ductal carcinoma is the most common form of breast cancer. Approximately80% of invasive breast cancers are invasive ductal carcinomas (American Cancer Society 2015a).
Invasive Lobular Carcinoma (ILC)
Invasive lobular carcinoma (ILC) starts in the lining of the lobules. It breaks through the wall of the lobule into the surrounding breast tissue, and from there, it can spread to the lymph nodes and other organs. Invasive lobular carcinoma accounts for approximately 10% of invasive breast cancer cases (American Cancer Society 2015a).
Inflammatory Breast Cancer (IBC)
Inflammatory breast cancer (IBC) is a rare but serious form of breast cancer. It accounts for only 1% to 3% of breast cancers (American Cancer Society 2015a). Inflammatory breast cancer causes the skin of the breast to feel warm and look red. It can also give the skin a thick, pitted appearance, similar to the peel of an orange. The breast itself may get bigger or feel itchy, tender, or hard. There may not be a single lump or tumor. In its early stages, inflammatory breast cancer is often mistaken for an infection rather than a cancer, and it may not be picked up by a mammogram.
Symptoms of Breast Cancer
The most common symptom of breast cancer is a lump or mass in the breast. Cancerous lumps tend to be painless and hard and have uneven edges, though this isn’t always the case. It is best to have any new changes in the breast looked at by a physician.
Other symptoms include
- Swelling in the breast
- Skin irritation or dimpling
- Breast or nipple pain
- The nipple inverting (turning inward on itself)
- Scaliness, redness, or thickening of the breast or nipple
- Nipple discharge that isn’t breast milk
With invasive cancers, it is possible for the cancer to spread to nearby lymph nodes under the arm or around the collarbone. A tumor may form there before the breast tumor is large enough to be felt.
Causes of Breast Cancer
Although the exact causes of breast cancer remain unknown, certain risk factors—things that increase an individual's chances of developing a cancer—have been identified. While risk factors may be useful in identifying high-risk individuals, they do not determine whether a person develops a disease. Some risk factors, such diet, are within an person’s control, while others, such as age, are not.
Some risk factors breast cancer include
- Gender: Women are 100 times more likely to develop breast cancer than men (one percent of men get breast cancer) (American Cancer Society 2015a).
- Age: As women get older, they are more likely to develop breast cancer.
- Genetic mutations: Certain genetic mutations (changes in the DNA sequence of a gene), such as mutations in the BRCA1 and BRCA2 genes, can increase a woman’s risk of developing breast cancer.
- Family history: Women with close blood relatives who have or have had breast cancer are at increased risk of developing the disease.
- Personal history: Women who have or have had breast cancer in one breast have an increased risk of developing breast cancer in the other breast or another part of the same breast. This is not the same as having a recurrence. A recurrence is when the same cancer returns
- Race: Overall, Caucasian women are slightly more likely to develop breast cancer than African American women.
- Dense breast tissue: Women, particularly younger women, with dense breast tissue have an increased risk of developing breast cancer.
- Certain benign breast problems: Having certain benign breast changes may increase a woman’s chances of developing breast cancer.
- Lobular carcinoma in situ (LCIS): When a woman is diagnosed with lobular carcinoma in situ, it means cells that look like cancer cells are in the lobules but cannot break through the walls of the duct or spread to other tissues or organs. LCIS can increase a woman’s chances of developing breast cancer later.
- Menstrual periods: Women who started menstruating early (before age 12) or underwent menopause late (after age 55) have a slightly increased risk of developing breast cancer.
- Breast radiation early in life
- Treatment with DES: Women who were treated with the drug DES (diethylstilbestrol) while pregnant have a slightly increased risk of developing breast cancer.
- Not having children or having children later l: There is a slight increase in risk for women who do not have children or begin having them after age 30 (American Cancer Society 2015b).
- Certain forms of birth control: Breast cancer risk is slightly higher for women actively using birth control pills or depot-medroxyprogesterone acetate (DMPA or Depo-Provera®), an injectable form of birth control.
- Breastfeeding versus not breastfeeding: Some studies have linked breastfeeding with a slight reduction in breast cancer risk for women, particularly if the woman breastfeeds for 1 ½ to 2 years (American Cancer Society 2015b).
- Hormone therapy after menopause: Treatment with estrogen and progesterone together (sometimes referred to as combined hormone therapy) after menopause increases a woman’s chances of developing breast cancer. Taking estrogen by itself does not seem to increase a woman’s chances of developing breast cancer, though it can increase her chances of developing other types of cancer.
- Alcohol consumption: The more alcohol a woman consumes on a daily basis, the higher her chances of developing the disease.
- Being overweight or obese
Patients with a strong family history of breast cancer may be eligible for genetic counseling. For more information, patients can visit Genetic Counseling or talk to their physician to request a referral.
Are You At Risk For Developing Breast Cancer?
American Cancer Society. 2015a. Detailed Guide: Breast Cancer. PDF.
-----.2015b. Overview Guide: Breast Cancer Overview. PDF.
National Cancer Institute. 2012. What You Need To Know About™ Breast Cancer. PDF. Bethesda: National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human
830 Harrison Avenue
Boston, MA 02118
Moakley Building 1st Floor
Monday - Friday 8:00 AM - 5:00 PM